Literature DB >> 34518659

Fixed-dose combination therapy and polypills to prevent and treat CVD.

Gregory B Lim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34518659     DOI： 10.1038/s41569-021-00614-4

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.

Authors:  Clara K Chow; Emily R Atkins; Graham S Hillis; Mark R Nelson; Christopher M Reid; Markus P Schlaich; Peter Hay; Kris Rogers; Laurent Billot; Michael Burke; John Chalmers; Bruce Neal; Anushka Patel; Tim Usherwood; Ruth Webster; Anthony Rodgers
Journal:  Lancet       Date:  2021-08-29       Impact factor: 79.321

2.  Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis.

Authors:  Philip Joseph; Gholamreza Roshandel; Peggy Gao; Prem Pais; Eva Lonn; Denis Xavier; Alvaro Avezum; Jun Zhu; Lisheng Liu; Karen Sliwa; Habib Gamra; Shrikant I Bangdiwala; Koon Teo; Rafael Diaz; Antonio Dans; Patricio Lopez-Jaramillo; Dorairaj Prabhakaran; Jose Maria Castellano; Valentin Fuster; Anthony Rodgers; Mark D Huffman; Jackie Bosch; Gilles R Dagenais; Reza Malekzadeh; Salim Yusuf
Journal:  Lancet       Date:  2021-08-29       Impact factor: 79.321
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.